Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Neoplasms 3 Lung Neoplasms 2 Chronic Disease 2 Urinary Bladder Neoplasms 1 This Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting. 1 Stress Disorders, Post-Traumatic 1 Parkinson Disease 1 Pancreatic Neoplasms 1 Pain, Intractable 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Non Metastatic Rectal Cancer 1 Neoplasms, Second Primary 1 Muscle Spasticity 1 Multiple Sclerosis 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Invasive Aspergillosis 1 Inflammatory Bowel Diseases 1 Immunoglobulin Light-chain Amyloidosis 1 Huntington Disease 1 Head and Neck Neoplasms 1 Glaucoma 1 Epilepsy 1 Dyskinesias 1 Colonic Neoplasms 1 Autism Spectrum Disorder 1 Anemia, Sickle Cell 1 Adenocarcinoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

Gemcitabine 157 Cisplatin 117 pembrolizumab 81 Cystectomy 46 Nivolumab 42 Carboplatin 42 Paclitaxel 41 Mitomycin 41 Docetaxel 39 atezolizumab 33 Magnetic Resonance Spectroscopy 33 Radiotherapy 31 durvalumab 30 avelumab 26 BCG Vaccine 26 Specimen Handling 25 Cystoscopy 24 enfortumab vedotin 23 Doxorubicin 23 Fluorouracil 20 Methotrexate 17 Vinblastine 16 Standard of Care 15 Ipilimumab 14 Filgrastim 14 5-aminolevulinic acid hexyl ester 14 Transurethral Resection of Bladder 13 Surgical Procedures, Operative 13 Sunitinib 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Registries × Clear all

NCT03413982 2026-03-10

GUB-BCR-001

University of Kansas Medical Center

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡